Analyzing a database of nearly 800 multiple
myeloma patient samples, they discovered that 162 patients with low ADAR1 levels in their tumor cells survived significantly longer over a three - year period compared to 159 patients with high ADAR1 levels.
Not exact matches
Researchers used tissue and blood
samples to show that the gammopathy (a precursor to
myeloma) in both mice and
patients with Gaucher disease is triggered by specific lipids, and that the antibodies made by tumor cells in nearly a third of
myeloma patients are directed against such lipids.
The researcher team from the University of Birmingham, New Cross and Heartlands Hospitals compared the cellular chemistry of bone marrow and blood
samples taken from
patients with
myeloma,
patients with MGUS and healthy volunteers.